29.08.2019 • NewsClariantDede Willams

Clariant Expands Catalyst Output in China

Chief operating officer Hans Bohnen said the project supports Clariant’s...
Chief operating officer Hans Bohnen said the project supports Clariant’s strategy of focusing on its core high-value specialty businesses to intensify growth, especially in major growth markets such as Asia-Pacific, in particular China

Clariant is planning a “significant” expansion of its catalyst production in Panjin, Liaoning province, northeast China. The Swiss specialty chemicals producer said the double-digit million Swiss franc investment sum will cover further optimization of an existing facility and enable the creation of a new state-of-the-art production line for its SynDane maleic anhydride (MA) catalyst.

Chief operating officer Hans Bohnen said the project supports Clariant’s strategy of focusing on its core high-value specialty businesses to intensify growth, especially in major growth markets such as Asia-Pacific, in particular China. The Swiss group added that the upgrade will help its customers meet the “dynamically growing” global demand for MA, for which production is expected to jump from 1.75 million t/y in 2018 to 2.07 million t/y in 2022.

The SynDane catalysts are said to be optimized for cost-efficient MA production via selective oxidation of n-butane in fixed-bed tubular reactors. Clariant said the catalysts’ superior yield, selectivity and operating stability greatly reduce the formation of byproducts such as acrylic acid and acetic acid as well as their downstream polymerization, thus minimizing downtime for equipment.

Since 2007, Clariant has produced the MA catalysts at Panjin in a joint venture with leading Chinese petrochemical producer North Huajin Chemical Industries. The Panjin site employs more than 140 people producing catalysts and adsorbents for production of butane-based maleic anhydride, ammonia, hydrogen, and methanol, as well as for other applications.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.